Late-pregnancy salivary cortisol concentrations of Ghanaian women participating in a randomized controlled trial of prenatal lipid-based nutrient supplements

Brietta M. Oaks, Kevin D. Laugero, Christine P. Stewart, Seth Adu-Afarwuah, Anna Lartey, Per Ashorn, Stephen A. Vosti, Kathryn G. Dewey

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: High circulating cortisol is associated with miscarriage, preterm birth, and low birth weight. Research in nonpregnant individuals suggests that improved nutrition may lower cortisol concentrations. It is unknown whether nutritional supplementation during pregnancy lowers cortisol. Objective: Our objective was to determine whether women receiving a lipid-based nutrient supplement (LNS) throughout pregnancy would have lower salivary cortisol at 36 wk gestation compared with women receiving other nutrient supplements. Methods: We conducted a randomized controlled trial in 1320 pregnant Ghanaian women at ≤20 wk gestation who were assigned to receive daily throughout pregnancy: 1) 60 mg iron + 400 mg folic acid (IFA), 2) multiple micronutrients (MMNs), or 3) 20 g LNS (containing 118 kcal, 22 micronutrients, and protein). Morning salivary cortisol was collected from a subsample at baseline and at 28 and 36 wk gestation. Results: A total of 758 women had cortisol measurements at 28 or 36 wk gestation. Salivary cortisol at 36 wk gestation did not differ between groups and was (mean ± SE) 7.97 ± 0.199 in the IFA group, 7.84 ± 0.191 in theMMN group, and 7.77 ± 0.199 nmol/L in the LNS group, when adjusted for baseline cortisol, time of waking, and time between waking and saliva collection (P = 0.67). Therewas an interaction between supplementation group andwomen's age (continuous variable, P-interaction = 0.03); and when agewas dichotomized by themedian, significant differences in salivary cortisol concentrations between groups were seen in women≤26 y of age (IFA = 8.23 ± 0.284 nmol/L, MMN= 8.20 ± 0.274 nmol/L, and LNS = 7.44 ± 0.284 nmol/L; P = 0.03) but not in women > 26 y old (IFA = 7.71 ± 0.281 nmol/L, MMN = 7.50 ± 0.274 nmol/L, and LNS = 8.08 ± 0.281 nmol/L; P = 0.13). Conclusions: We conclude that supplementation with LNSs or MMNs during pregnancy did not affect the cortisol concentration in the study population as a whole, in comparison with IFA, but that LNS consumption among younger women may lead to lower cortisol at 36 wk gestation. This trial was registered at clinicaltrials.gov as NCT00970866.

Original languageEnglish (US)
Pages (from-to)343-352
Number of pages10
JournalJournal of Nutrition
Volume146
Issue number2
DOIs
StatePublished - 2016

Fingerprint

Hydrocortisone
Randomized Controlled Trials
Lipids
Food
Pregnancy
Micronutrients
Folic Acid
Iron
Premature Birth
Low Birth Weight Infant
Spontaneous Abortion
Saliva
Pregnant Women
Age Groups
Research

Keywords

  • Cortisol
  • Ghana
  • Lipid-based nutrient supplements
  • Micronutrient supplements
  • Pregnancy

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Medicine(all)

Cite this

Late-pregnancy salivary cortisol concentrations of Ghanaian women participating in a randomized controlled trial of prenatal lipid-based nutrient supplements. / Oaks, Brietta M.; Laugero, Kevin D.; Stewart, Christine P.; Adu-Afarwuah, Seth; Lartey, Anna; Ashorn, Per; Vosti, Stephen A.; Dewey, Kathryn G.

In: Journal of Nutrition, Vol. 146, No. 2, 2016, p. 343-352.

Research output: Contribution to journalArticle

Oaks, Brietta M. ; Laugero, Kevin D. ; Stewart, Christine P. ; Adu-Afarwuah, Seth ; Lartey, Anna ; Ashorn, Per ; Vosti, Stephen A. ; Dewey, Kathryn G. / Late-pregnancy salivary cortisol concentrations of Ghanaian women participating in a randomized controlled trial of prenatal lipid-based nutrient supplements. In: Journal of Nutrition. 2016 ; Vol. 146, No. 2. pp. 343-352.
@article{73bbe2ff541340c2acd840067a17f160,
title = "Late-pregnancy salivary cortisol concentrations of Ghanaian women participating in a randomized controlled trial of prenatal lipid-based nutrient supplements",
abstract = "Background: High circulating cortisol is associated with miscarriage, preterm birth, and low birth weight. Research in nonpregnant individuals suggests that improved nutrition may lower cortisol concentrations. It is unknown whether nutritional supplementation during pregnancy lowers cortisol. Objective: Our objective was to determine whether women receiving a lipid-based nutrient supplement (LNS) throughout pregnancy would have lower salivary cortisol at 36 wk gestation compared with women receiving other nutrient supplements. Methods: We conducted a randomized controlled trial in 1320 pregnant Ghanaian women at ≤20 wk gestation who were assigned to receive daily throughout pregnancy: 1) 60 mg iron + 400 mg folic acid (IFA), 2) multiple micronutrients (MMNs), or 3) 20 g LNS (containing 118 kcal, 22 micronutrients, and protein). Morning salivary cortisol was collected from a subsample at baseline and at 28 and 36 wk gestation. Results: A total of 758 women had cortisol measurements at 28 or 36 wk gestation. Salivary cortisol at 36 wk gestation did not differ between groups and was (mean ± SE) 7.97 ± 0.199 in the IFA group, 7.84 ± 0.191 in theMMN group, and 7.77 ± 0.199 nmol/L in the LNS group, when adjusted for baseline cortisol, time of waking, and time between waking and saliva collection (P = 0.67). Therewas an interaction between supplementation group andwomen's age (continuous variable, P-interaction = 0.03); and when agewas dichotomized by themedian, significant differences in salivary cortisol concentrations between groups were seen in women≤26 y of age (IFA = 8.23 ± 0.284 nmol/L, MMN= 8.20 ± 0.274 nmol/L, and LNS = 7.44 ± 0.284 nmol/L; P = 0.03) but not in women > 26 y old (IFA = 7.71 ± 0.281 nmol/L, MMN = 7.50 ± 0.274 nmol/L, and LNS = 8.08 ± 0.281 nmol/L; P = 0.13). Conclusions: We conclude that supplementation with LNSs or MMNs during pregnancy did not affect the cortisol concentration in the study population as a whole, in comparison with IFA, but that LNS consumption among younger women may lead to lower cortisol at 36 wk gestation. This trial was registered at clinicaltrials.gov as NCT00970866.",
keywords = "Cortisol, Ghana, Lipid-based nutrient supplements, Micronutrient supplements, Pregnancy",
author = "Oaks, {Brietta M.} and Laugero, {Kevin D.} and Stewart, {Christine P.} and Seth Adu-Afarwuah and Anna Lartey and Per Ashorn and Vosti, {Stephen A.} and Dewey, {Kathryn G.}",
year = "2016",
doi = "10.3945/jn.115.219576",
language = "English (US)",
volume = "146",
pages = "343--352",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "2",

}

TY - JOUR

T1 - Late-pregnancy salivary cortisol concentrations of Ghanaian women participating in a randomized controlled trial of prenatal lipid-based nutrient supplements

AU - Oaks, Brietta M.

AU - Laugero, Kevin D.

AU - Stewart, Christine P.

AU - Adu-Afarwuah, Seth

AU - Lartey, Anna

AU - Ashorn, Per

AU - Vosti, Stephen A.

AU - Dewey, Kathryn G.

PY - 2016

Y1 - 2016

N2 - Background: High circulating cortisol is associated with miscarriage, preterm birth, and low birth weight. Research in nonpregnant individuals suggests that improved nutrition may lower cortisol concentrations. It is unknown whether nutritional supplementation during pregnancy lowers cortisol. Objective: Our objective was to determine whether women receiving a lipid-based nutrient supplement (LNS) throughout pregnancy would have lower salivary cortisol at 36 wk gestation compared with women receiving other nutrient supplements. Methods: We conducted a randomized controlled trial in 1320 pregnant Ghanaian women at ≤20 wk gestation who were assigned to receive daily throughout pregnancy: 1) 60 mg iron + 400 mg folic acid (IFA), 2) multiple micronutrients (MMNs), or 3) 20 g LNS (containing 118 kcal, 22 micronutrients, and protein). Morning salivary cortisol was collected from a subsample at baseline and at 28 and 36 wk gestation. Results: A total of 758 women had cortisol measurements at 28 or 36 wk gestation. Salivary cortisol at 36 wk gestation did not differ between groups and was (mean ± SE) 7.97 ± 0.199 in the IFA group, 7.84 ± 0.191 in theMMN group, and 7.77 ± 0.199 nmol/L in the LNS group, when adjusted for baseline cortisol, time of waking, and time between waking and saliva collection (P = 0.67). Therewas an interaction between supplementation group andwomen's age (continuous variable, P-interaction = 0.03); and when agewas dichotomized by themedian, significant differences in salivary cortisol concentrations between groups were seen in women≤26 y of age (IFA = 8.23 ± 0.284 nmol/L, MMN= 8.20 ± 0.274 nmol/L, and LNS = 7.44 ± 0.284 nmol/L; P = 0.03) but not in women > 26 y old (IFA = 7.71 ± 0.281 nmol/L, MMN = 7.50 ± 0.274 nmol/L, and LNS = 8.08 ± 0.281 nmol/L; P = 0.13). Conclusions: We conclude that supplementation with LNSs or MMNs during pregnancy did not affect the cortisol concentration in the study population as a whole, in comparison with IFA, but that LNS consumption among younger women may lead to lower cortisol at 36 wk gestation. This trial was registered at clinicaltrials.gov as NCT00970866.

AB - Background: High circulating cortisol is associated with miscarriage, preterm birth, and low birth weight. Research in nonpregnant individuals suggests that improved nutrition may lower cortisol concentrations. It is unknown whether nutritional supplementation during pregnancy lowers cortisol. Objective: Our objective was to determine whether women receiving a lipid-based nutrient supplement (LNS) throughout pregnancy would have lower salivary cortisol at 36 wk gestation compared with women receiving other nutrient supplements. Methods: We conducted a randomized controlled trial in 1320 pregnant Ghanaian women at ≤20 wk gestation who were assigned to receive daily throughout pregnancy: 1) 60 mg iron + 400 mg folic acid (IFA), 2) multiple micronutrients (MMNs), or 3) 20 g LNS (containing 118 kcal, 22 micronutrients, and protein). Morning salivary cortisol was collected from a subsample at baseline and at 28 and 36 wk gestation. Results: A total of 758 women had cortisol measurements at 28 or 36 wk gestation. Salivary cortisol at 36 wk gestation did not differ between groups and was (mean ± SE) 7.97 ± 0.199 in the IFA group, 7.84 ± 0.191 in theMMN group, and 7.77 ± 0.199 nmol/L in the LNS group, when adjusted for baseline cortisol, time of waking, and time between waking and saliva collection (P = 0.67). Therewas an interaction between supplementation group andwomen's age (continuous variable, P-interaction = 0.03); and when agewas dichotomized by themedian, significant differences in salivary cortisol concentrations between groups were seen in women≤26 y of age (IFA = 8.23 ± 0.284 nmol/L, MMN= 8.20 ± 0.274 nmol/L, and LNS = 7.44 ± 0.284 nmol/L; P = 0.03) but not in women > 26 y old (IFA = 7.71 ± 0.281 nmol/L, MMN = 7.50 ± 0.274 nmol/L, and LNS = 8.08 ± 0.281 nmol/L; P = 0.13). Conclusions: We conclude that supplementation with LNSs or MMNs during pregnancy did not affect the cortisol concentration in the study population as a whole, in comparison with IFA, but that LNS consumption among younger women may lead to lower cortisol at 36 wk gestation. This trial was registered at clinicaltrials.gov as NCT00970866.

KW - Cortisol

KW - Ghana

KW - Lipid-based nutrient supplements

KW - Micronutrient supplements

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84951837022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951837022&partnerID=8YFLogxK

U2 - 10.3945/jn.115.219576

DO - 10.3945/jn.115.219576

M3 - Article

VL - 146

SP - 343

EP - 352

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 2

ER -